Reactions to the proposed ban of PFAS
by Giuliana Miglierini A proposal to ban around 10,000 per- and polyfluoroalkyl substances (PFAS) was submitted in January…
EC Communication (part 2): a Critical Medicines Alliance to support European pharma supply chain
by Giuliana Miglierini After last week’s examination of the first part of the Commission’s Communication, specifically targeted to…
Review of the pharmaceutical legislation, the proposals of the industrial associations
By Giuliana Miglierini The Staff Working Document on “Vulnerabilities of the global supply chains of medicines” published by…
EMA’s Industry stakeholders group (ISG)
by Giuliana Miglierini The Industrial Stakeholder Group (ISG) is a new initiative recently launched by the European Medicines…
A new role for EMA and a pilot project for the repurposing of medicines
by Giuliana Miglierini A draft agreement was reached at the end of October between the Council of the…
Consultation on the reform of the European pharmaceutical legislation
by Giuliana Miglierini A new step in the review of the overall framework governing the pharmaceutical sector has…